Search - tctmd.com

Displaying 241 - 260 of 352

Sort: Relevancy | Date

News Conference News ACC 2014

Renal Denervation Fails to Meet Efficacy Endpoints Compared with Placebo Procedure

Yael L. Maxwell

March 29, 2014

News Industry News

ANTI-CLOTTING AGENT HELPS REDUCE THE INCIDENCE AND IMPACT OF STENT THROMBOSIS DURING PERCUTANEOUS CORONARY INTERVENTION

March 27, 2014

News Daily News

DAPT Interruption At Least 1 Month After ZES Implantation Appears Safe

Yael L. Maxwell

February 17, 2014

News Industry News

Medtronic Announces U.S. Renal Denervation Pivotal Trial Fails to Meet Primary Efficacy Endpoint While Meeting Primary Safety Endpoint

January 08, 2014

Presentation TCT 2013

The Case for Intravenous Cangrelor as the Preferred ADP Antagonist to Support Primary PCI

Presenter: Deepak Bhatt

October 30, 2013

Presentation TCT 2013

Important Lessons from SIMPLICITY HTN-3 (Inclusion Criteria, Site Selection, and Study Endpoints): What I Would Do Differently Next Time?

Presenter: Deepak Bhatt

October 30, 2013

Presentation

Welcome and Introductions/Pre-test

Presenter: Deepak Bhatt

October 29, 2013

Presentation

Perspectives in Individualized Antiplatelet Therapy: Comorbidities and Characteristics

Presenter: Deepak Bhatt

October 29, 2013

News Industry News

Anti-Clotting Agent Helps Reduce the Risk of Intraprocedural Events during Percutaneous Coronary Intervention

October 28, 2013

News Daily News

Longer DAPT Duration Reduces Adverse Events After PCI for In-Stent Restenosis

Caitlin E. Cox

October 23, 2013

News Daily News

TRILOGY ACS Substudy: Prasugrel Post-Angiography Minimizes Risk of Adverse Events

Yael L. Maxwell

August 23, 2013

News Daily News

Subestudio del TRILOGY ACS: El Prasugrel Post-Angiografía Minimiza el Riesgo de Episodios Adversos

Yael L. Maxwell

August 23, 2013

News Daily News

PLATO: 与氯吡格雷相比替卡格雷可以全面减少ACS患者支架内血栓形成

Caitlin E. Cox

August 12, 2013

News Daily News

PLATO: Ticagrelor Lowers Stent Thrombosis vs. Clopidogrel Across the Board in ACS

Caitlin E. Cox

August 12, 2013

News Daily News

PLATO: En Líneas Generales, el Ticagrelor Reduce la Trombosis del Stent frente al Clopidogrel en el Tratamiento del SCA

Caitlin E. Cox

August 12, 2013

News Daily News

Renal Denervation Safe, Effective for Moderate Resistant Hypertension in Pilot Study

July 19, 2013

News Daily News

La Denervación Renal es Segura y Eficaz contra la Hipertensión Resistente Moderada en un Estudio Piloto

July 19, 2013

News Industry News

FDA Accepts the Filing of The Medicines Company's New Drug Application for Intravenous Antiplatelet Agent Cangrelor

July 01, 2013

News Daily News

Renal Denervation Lowers Ambulatory BP Measurements in Resistant Hypertension

June 28, 2013

News Daily News

Denervación renal disminuye los índices de PA ambulatoria en la hipertensión resistente

June 28, 2013

Advertisement

Renal Denervation Fails to Meet Efficacy Endpoints Compared with Placebo Procedure

ANTI-CLOTTING AGENT HELPS REDUCE THE INCIDENCE AND IMPACT OF STENT THROMBOSIS DURING PERCUTANEOUS CORONARY INTERVENTION

DAPT Interruption At Least 1 Month After ZES Implantation Appears Safe

Medtronic Announces U.S. Renal Denervation Pivotal Trial Fails to Meet Primary Efficacy Endpoint While Meeting Primary Safety Endpoint

The Case for Intravenous Cangrelor as the Preferred ADP Antagonist to Support Primary PCI

Important Lessons from SIMPLICITY HTN-3 (Inclusion Criteria, Site Selection, and Study Endpoints): What I Would Do Differently Next Time?

Welcome and Introductions/Pre-test

Perspectives in Individualized Antiplatelet Therapy: Comorbidities and Characteristics

Anti-Clotting Agent Helps Reduce the Risk of Intraprocedural Events during Percutaneous Coronary Intervention

Longer DAPT Duration Reduces Adverse Events After PCI for In-Stent Restenosis

TRILOGY ACS Substudy: Prasugrel Post-Angiography Minimizes Risk of Adverse Events

Subestudio del TRILOGY ACS: El Prasugrel Post-Angiografía Minimiza el Riesgo de Episodios Adversos

PLATO: 与氯吡格雷相比替卡格雷可以全面减少ACS患者支架内血栓形成

PLATO: Ticagrelor Lowers Stent Thrombosis vs. Clopidogrel Across the Board in ACS

PLATO: En Líneas Generales, el Ticagrelor Reduce la Trombosis del Stent frente al Clopidogrel en el Tratamiento del SCA

Renal Denervation Safe, Effective for Moderate Resistant Hypertension in Pilot Study

La Denervación Renal es Segura y Eficaz contra la Hipertensión Resistente Moderada en un Estudio Piloto

FDA Accepts the Filing of The Medicines Company's New Drug Application for Intravenous Antiplatelet Agent Cangrelor

Renal Denervation Lowers Ambulatory BP Measurements in Resistant Hypertension

Denervación renal disminuye los índices de PA ambulatoria en la hipertensión resistente

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content